UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
March 23, 2021
Accession Number:
Submission Type:
CIK:
0001321834
Company Name:
Akers Biosciences, Inc.
File Number:
333-252181